Organovo (ONVO)
(Delayed Data from NSDQ)
$0.50 USD
-0.01 (-2.09%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.48 -0.02 (-3.30%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Organovo Holdings, Inc falls in the month of March .
All items in Millions except EPS data.
3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 2 | 0 | 2 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 2 | 0 | 2 |
Selling & Adminstrative & Depr. & Amort Expenses | 15 | 18 | 13 | 17 | 23 |
Income After Depreciation & Amortization | -15 | -18 | -11 | -17 | -21 |
Non-Operating Income | 0 | 0 | 0 | 0 | 3 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -15 | -17 | -11 | -17 | -19 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -15 | -17 | -11 | -17 | -19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -15 | -17 | -11 | -17 | -19 |
Depreciation Footnote | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -17 | -11 | -17 | -20 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 1 |
Income After Depreciation & Amortization | -15 | -18 | -11 | -17 | -21 |
Earnings Per Share Data | 3/31/24 | 3/31/23 | 3/31/22 | 3/31/21 | 3/31/20 |
---|---|---|---|---|---|
Average Shares | 9.15 | 8.71 | 8.70 | 6.90 | NA |
Diluted EPS Before Non-Recurring Items | -1.60 | -1.98 | -1.32 | -2.44 | NA |
Diluted Net EPS (GAAP) | -1.60 | -1.98 | -1.32 | -2.44 | -2.80 |
Fiscal Year end for Organovo Holdings, Inc falls in the month of March .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.04 | 0.03 | 0.01 | 0.00 | 0.08 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.04 | 0.03 | 0.01 | 0.00 | 0.08 |
SG&A, R&D, and Dept/Amort Expenses | 3.42 | 3.12 | 3.68 | 4.12 | 4.27 |
Income After SG&A, R&D, and Dept/Amort Expenses | -3.38 | -3.09 | -3.67 | -4.12 | -4.19 |
Non-Operating Income | 0.04 | 0.05 | 0.08 | 0.12 | 0.17 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -3.34 | -3.05 | -3.60 | -3.99 | -4.03 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -3.34 | -3.05 | -3.60 | -3.99 | -4.03 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -3.34 | -3.05 | -3.60 | -3.99 | -4.03 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 14.66 | 10.47 | 9.12 | 8.72 | 8.72 |
Diluted EPS Before Non-Recurring Items | -0.23 | -0.29 | -0.40 | -0.46 | -0.46 |
Diluted Net EPS (GAAP) | -0.23 | -0.28 | -0.40 | -0.46 | -0.46 |